Dr Manasi Kadam Ladrigan, MD - Medicare Dermatology in Rochester, NY

Dr Manasi Kadam Ladrigan, MD is a medicare enrolled "Dermatology" physician in Rochester, New York. She went to State University Of New York At Buffalo School Of Medicine and graduated in 2004 and has 20 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Comprehensive Dermatology Of Rochester Pllc and her current practice location is 900 Winton Rd S, Rochester, New York. You can reach out to her office (for appointments etc.) via phone at (585) 381-5800.

Dr Manasi Kadam Ladrigan is licensed to practice in New York (license number 242371) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1366457814.

Contact Information

Dr Manasi Kadam Ladrigan, MD
900 Winton Rd S,
Rochester, NY 14618-1628
(585) 381-5800
(585) 348-9461



Physician's Profile

Full NameDr Manasi Kadam Ladrigan
GenderFemale
SpecialityDermatology
Experience20 Years
Location900 Winton Rd S, Rochester, New York
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Manasi Kadam Ladrigan attended and graduated from State University Of New York At Buffalo School Of Medicine in 2004
  NPI Data:
  • NPI Number: 1366457814
  • Provider Enumeration Date: 07/30/2006
  • Last Update Date: 09/16/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4880842715
  • Enrollment ID: I20121009000574

Medical Identifiers

Medical identifiers for Dr Manasi Kadam Ladrigan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1366457814NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 242371 (New York)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Comprehensive Dermatology Of Rochester Pllc39717518014

News Archive

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

Mobile health technology has potential to transform prevention, management of heart disease

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement with patients, according to a review of randomized clinical trials published in the Canadian Journal of Cardiology.

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Manasi Kadam Ladrigan allows following entities to bill medicare on her behalf.
Entity NameRochester General Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1356412712
PECOS PAC ID: 0244149474
Enrollment ID: O20031121000644

News Archive

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

Mobile health technology has potential to transform prevention, management of heart disease

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement with patients, according to a review of randomized clinical trials published in the Canadian Journal of Cardiology.

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

Read more Medical News

› Verified 8 days ago

Entity NameWestern New York Medical Practice Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063790608
PECOS PAC ID: 3870767791
Enrollment ID: O20111110000598

News Archive

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

Mobile health technology has potential to transform prevention, management of heart disease

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement with patients, according to a review of randomized clinical trials published in the Canadian Journal of Cardiology.

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

Read more Medical News

› Verified 8 days ago

Entity NameComprehensive Dermatology Of Rochester Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710235536
PECOS PAC ID: 3971751801
Enrollment ID: O20120918000276

News Archive

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

Mobile health technology has potential to transform prevention, management of heart disease

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement with patients, according to a review of randomized clinical trials published in the Canadian Journal of Cardiology.

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Manasi Kadam Ladrigan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Manasi Kadam Ladrigan, MD
900 Winton Rd S,
Rochester, NY 14618-1628

Ph: (585) 381-5800
Dr Manasi Kadam Ladrigan, MD
900 Winton Rd S,
Rochester, NY 14618-1628

Ph: (585) 381-5800

News Archive

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

Mobile health technology has potential to transform prevention, management of heart disease

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement with patients, according to a review of randomized clinical trials published in the Canadian Journal of Cardiology.

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

Read more News

› Verified 8 days ago


Dermatology Doctors in Rochester, NY

Dr. Yana Veyberman Ignatovich, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 120 Erie Canal Dr, Rochester, NY 14626
Phone: 585-719-9600    
Dr. Walter S Brooks, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 730 Weiland Rd, Rochester, NY 14626
Phone: 585-719-9600    Fax: 585-719-9872
Dr. Leena Mehta, MD
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 2211 Lyell Ave, Rochester, NY 14606
Phone: 585-429-5555    Fax: 585-429-6581
Dr. Christopher Brent Yelverton, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 10 Hagen Dr Ste 300, Rochester, NY 14625
Phone: 585-922-9770    Fax: 585-922-9733
Jonathan Matthew Soh, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 505 Beahan Rd, Rochester, NY 14624
Phone: 716-755-6647    Fax: 716-755-6648
Dr. Lesley C Loss, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 100 White Spruce Blvd, Rochester, NY 14623
Phone: 585-272-0700    Fax: 585-272-8356
Allison L Holm, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 30 N Union St, Suite 105, Rochester, NY 14607
Phone: 585-232-8940    Fax: 585-232-8687

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.